Booking 20.91% Profits, Locking in 15% Gains

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

Last week was a flat-to-negative one for U.S. and global stock markets. The Dow Jones fell 0.22%, the S&P 500 rose 0.16% and the NASDAQ gained 0.81%. The MCSI Emerging Markets Index pulled back 0.95%.

Big gainers in your Bull Market Alert portfolio included Regeneron (REGN), which powered up 5.09%; ProShares Ultra Nasdaq Biotechnology ETF (BIB), which jumped 4.90%; Ambarella Inc. (AMBA), which gained 4.78%; and Integrated Device Technology (IDTI), which climbed 2.94%.

Three of these positions, Integrated Device Technology (IDTI), Regeneron (REGN) and Ambarella Inc. (AMBA), hit new 52-week highs.

The WisdomTree Europe Hedged Equity Fund (HEDJ) moved back above its 50-day moving average and is now a BUY. All positions in your Bull Market Alert portfolio are a BUY except for Halyard Health Inc. (HYH).

This week, with the market at the top end of its trading range and on the cusp of entering the worst month of the year in June, I am recommending that you close your position in the Direxion Daily Small Cap Bull 3x ETF (TNA) for a 4.08% gain. Also sell your related TNA June $84 call options (TNA150619C00084000) to lock in an 20.91% gain.

Also, raise your stop in Integrated Device Technology (IDTI) to $22.30 to lock in at least a 15% gain in the stock.

Although the S&P 500 broke out to the upside last week, there wasn’t a lot of celebration on Wall Street.

That’s because there hasn’t been a lot of oomph behind its move. According to Sentimentrader.com, there have been only four times in the past 15 years that the S&P 500 has traded to a new 52-week high while not moving more than 1%.

Exclusive  A Stock Market Anniversary Lesson… Don’t Be a Loser

And according to Bloomberg, when the S&P closed at a new all-time high on Thursday, only 10% of its component stocks were trading at even a four-week high. And nearly 3% of components were trading at a four-week low. That net of +7% is one of the weakest readings in 25 years. Over the course of the past 10 years, this has signaled weakness going forward, at least over the next couple of months.

So I am going to hold off making a new Bull Market Alert recommendation this holiday-shortened week and will monitor the market closely before proposing a new recommendation in the next four weeks or so.

Portfolio Update

ProShares Ultra Nasdaq Biotechnology ETF (BIB) jumped 4.90% last week, continuing a third week of gains. This exchange-traded fund (ETF) split 2:1 last Wednesday. BIB has been historically a strong gainer, but recently hit a double top at the $90 price level. More often than not, splits have the peculiar result of pushing positions higher after the split occurs. With this position currently approaching $90 for a third time, the recent split may be just the catalyst to push BIB higher still. BIB is a BUY.

Integrated Device Technology (IDTI) gained 2.94%. Like BIB, IDTI closed a third week of gains last week to make a new 52-week high. IDTI continues to bask in the glow of its recent positive earnings report as investors continue their buying spree. Raise your stop to $22.30 to lock in at least a 15% gain in this stock. IDTI is a BUY.

iShares MSCI Hong Kong (EWH) rose 1.28%, closing the week just a few cents under its recent 52-week high. With expectations of further economic policy easing coming to China, a positive ripple effect may spread to other local regions, including Hong Kong. EWH has been significantly outperforming U.S. markets this year, and this trend should persist. EWH remains a BUY.

Exclusive  A Dangerous Glitch in the ETF Matrix

Regeneron (REGN) powered 5.09% higher last week to hit a new 52-week high. Regeneron is another recommendation in your portfolio marking strong and continued gains on the back of a recent positive earnings report. Several analysts’ firms reiterated their “Buy” ratings last week and increased their price targets, including Brean Capital moving its target on REGN to $525, Argus to $560 and Canaccord Genuity to $600. As CNBC’s “Mad Money” host Jim Cramer said, “This stock is not done rising yet!” REGN is a BUY.

Ambarella Inc. (AMBA) followed up with another strong week and has now gained 4.76% since being added to your portfolio. AMBA also marked a new 52-week high last week. This positive trading action is likely from investors getting into position for AMBA’s upcoming earnings report, to be released on June 2 after markets close. AMBA is a BUY.

NEW FEATURE — Receive your alerts via text! You now can receive a text message on your cell phone to inform you whenever a trading alert is sent. To add this free new benefit to your service, please send an email to CustomerService@NicholasVardy.com with the following information and mention in the email that you want your cell phone added to your account:

  • Your Name
  • Your Zip Code
  • Your Email Address
  • Your Cell Phone number

Please note that we can only deliver text messages to cell phones with U.S. or Canadian numbers. Standard text messaging rates from your provider apply.

Nicholas Vardy

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE


img
previous article

LQD gives exposure to a range of domestic investment-grade corporate bonds, primarily to large and well-known companies.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE